MED15::ATF1-Rearranged Tumor: A Novel Cutaneous Tumor With Melanocytic Differentiation
Modern Pathology · 2024
DOI: 10.1016/j.modpat.2024.100438 ↗Kurz gefasst
Fallbericht in der Zeitschrift Modern Pathology, 2024. Verfasst von Jennifer S Ko und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Cleveland Clinic, Cleveland, Ohio. Electronic address: Koj2@ccf.org. Hauptthemen laut MEDLINE: Melanoma, Sarcoma, Clear Cell, Skin Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
We recently described novel dermal tumors with melanocytic differentiation and morphologic and biological similarities to cutaneous clear cell sarcoma, including CRTC1::TRIM11 cutaneous tumor, and clear cell tumors with melanocytic differentiation and either ACTIN::MITF or MITF::CREM. Here, we describe a series of 3 patients presenting with tumors reminiscent of CRTC1::TRIM11 cutaneous tumor, found to demonstrate a novel MED15::ATF1 fusion. All 3 patients were children (5-16 years old). Primary excision of case 1 showed a circumscribed wedge-shaped silhouette with peripheral intercalation into collagen fibers and scattered lymphoid aggregates. All 3 tumors abutted the epidermis; one showed a junctional component. Tumors were highly cellular and comprised of monomorphic, oval-to-round epithelioid cells arranged in vague nests and short fascicles in variably fibrotic stroma. Mitotic rate was high (hotspot 6-12/mm2), without atypical mitoses. Necrosis was focally present in case 3. All cases showed strong, diffuse nuclear staining for SOX10 and MITF (2/2) but showed variable expression for S100 protein (1/3) and other melanocytic markers-Melan-A (focal in 2/3), HMB45 (focal in 1/3), and Pan-Melanoma (patchy in 1/1). Whole-exome RNA sequencing demonstrated a MED15::ATF1 fusion without any other notable alterations. Cases 1 and 2 were completely excised without recurrence (12 months). Case 3 developed a grossly apparent regional lymph node spread shortly after primary biopsy. The patient was treated with wide excision, radiation, cervical lymph node dissection (4/46 with >75% lymph node replacement), and neoadjuvant and adjuvant nivolumab (alive without disease at cycle 11). This series is presented to aid in future diagnosis of this novel dermal tumor with melanocytic differentiation and emphasize the potential for aggressive biologic behavior, which should be considered in patient management planning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Cleveland Clinic, Cleveland, Ohio. Electronic address: Koj2@ccf.org.
- Dermpat Lab, Ghent, Belgium.
- Department of Pathology, Cleveland Clinic, Cleveland, Ohio.
- Department of Pathobiology, Centre Léon Bérard, Lyon, France; INSERM 1052, CNRS 5286, Research Cancer Center of Lyon, Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon, France.
- Anatomic Pathology, Royal Brisbane and Women's Hospital and Queensland Children's Hospital, Brisbane, Australia.
- Dermatology Department, Ghent University Hospital, Ghent, Belgium.
Zitieren
APA
Ko, J. S., Lemahieu, J., Billings, S. D., Tirode, F., Payton, D., Boone, B., Pissaloux, D., & de la Fouchardiere, A. (2024). MED15::ATF1-Rearranged Tumor: A Novel Cutaneous Tumor With Melanocytic Differentiation. Modern Pathology. https://doi.org/10.1016/j.modpat.2024.100438
Vancouver
Ko JS, Lemahieu J, Billings SD, Tirode F, Payton D, Boone B, et al. MED15::ATF1-Rearranged Tumor: A Novel Cutaneous Tumor With Melanocytic Differentiation. Modern Pathology. 2024. doi:10.1016/j.modpat.2024.100438
BibTeX
@article{Ko2024,
author = {Ko, Jennifer S and Lemahieu, Julie and Billings, Steven D and Tirode, Franck and Payton, Diane and Boone, Barbara and Pissaloux, Daniel and de la Fouchardiere, Arnaud},
title = {MED15::ATF1-Rearranged Tumor: A Novel Cutaneous Tumor With Melanocytic Differentiation},
journal = {Modern Pathology},
year = {2024},
doi = {10.1016/j.modpat.2024.100438}
}
EUVIMED